This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cyberonics: Growth in Medical Equipment

  • Revenue projected to increase by 1.90% this year and 3.10% next year
  • Earning estimated to be up 5.80% this year and 5.50% next year
  • TheStreet readers rate the stock A-
  • Baxter International:
  • Revenue projected to increase by 2.50% this year and 4.50% next year
  • Earnings estimated to be up 5.10% this year and 8.20% next year
  • TheStreet readers rate the stock A-
  • Covidien:
  • Revenue projected to be up 2.80% this year and 4.80% next year
  • Earnings estimated to increase by 8.30% this year and 7.70% next year
  • The readers of TheStreet rate the stock A-
  • Summary: Cyberonics has double-digit projections for both sales and earnings and a B+ balance sheet. The recent price momentum shows others are finding this stock. The readers of TheStreet rate all four stocks A- but CYBX has superior growth projections. To make sure you are not too late to the party I'd advise you to watch the 100-day moving average and the lower 14-day turtle chart if a weakness is signalled:

    At the time of publication the author had no shares of Cyberonics although it is on his watch list.
    At the time of publication the author had no shares of Cyberonics although it is on his watch list.
    2 of 2

    Check Out Our Best Services for Investors

    Action Alerts PLUS

    Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

    Product Features:
    • $2.5+ million portfolio
    • Large-cap and dividend focus
    • Intraday trade alerts from Cramer
    Quant Ratings

    Access the tool that DOMINATES the Russell 2000 and the S&P 500.

    Product Features:
    • Buy, hold, or sell recommendations for over 4,300 stocks
    • Unlimited research reports on your favorite stocks
    • A custom stock screener
    Stocks Under $10

    David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

    Product Features:
    • Model portfolio
    • Stocks trading below $10
    • Intraday trade alerts
    14-Days Free
    Only $9.95
    14-Days Free
    Dividend Stock Advisor

    David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

    Product Features:
    • Diversified model portfolio of dividend stocks
    • Updates with exact steps to take - BUY, HOLD, SELL
    Trifecta Stocks

    Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

    Product Features:
    • Model Portfolio
    • Intra Day Trade alerts
    • Access to Quant Ratings
    Real Money

    More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

    Product Features:
    • Access to Jim Cramer's daily blog
    • Intraday commentary and news
    • Real-time trading forums
    Only $49.95
    14-Days Free
    14-Days Free
    CYBX $69.95 1.24%
    BAX $37.94 0.77%
    COV $106.71 -1.26%
    MDT $76.51 1.55%
    AAPL $117.34 -0.81%


    Chart of I:DJI
    DOW 17,888.35 +168.43 0.95%
    S&P 500 2,102.63 +22.22 1.07%
    NASDAQ 5,156.3060 +47.64 0.93%

    Free Reports

    Top Rated Stocks Top Rated Funds Top Rated ETFs